سعر سينجولير 4مجم اطفال 14 قرص للمضغ 2024

Montelukast 4 mg paediatric chewable tablets (SINGULAIR, MSD) for asthma and allergic rhinitis in children 2-5 years, Egyptian market.

• Prophylaxis and chronic treatment of asthma (from 12 months); prevention of exercise-induced bronchoconstriction (from 6 years); relief of seasonal (from 2 years) and perennial (from 6 months) allergic rhinitis, reserved for patients with inadequate response or intolerance to alternative therapies. Not for acute asthma attacks.Population: US label age bands by strength: 10 mg tablet ≥15 years; 5 mg chewable 6-14 years; 4 mg chewable 2-5 yearsDailyMed (U.S. National Library of Medicine)

• Most common (≥5% and greater than placebo): upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhoea, otitis media, influenza, rhinorrhoea, sinusitis, otitis.International label, same product · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any of its components.International label, same product · DailyMed (U.S. National Library of Medicine)

• Boxed warning: serious neuropsychiatric events (agitation, aggression, depression, sleep disturbances, suicidal thoughts and behaviour including suicide) have been reported. Benefits may not outweigh risks in some patients, particularly with mild symptoms; reserve use in allergic rhinitis for inadequate response or intolerance to alternatives; discuss risks and stop if symptoms occur.International label, same product · DailyMed (U.S. National Library of Medicine)
• Not for reversal of bronchospasm in acute asthma attacks; keep rescue medication available. Do not abruptly substitute for inhaled or oral corticosteroids. Aspirin-sensitive patients should continue to avoid aspirin/NSAIDs. Systemic eosinophilia, sometimes with vasculitis consistent with Churg-Strauss syndrome, has been reported, sometimes with oral corticosteroid reduction.International label, same product · DailyMed (U.S. National Library of Medicine)
• SINGULAIR chewable tablets contain aspartame (phenylalanine): 0.674 mg per 4 mg tablet and 0.842 mg per 5 mg tablet; consider total phenylalanine intake in phenylketonuria.International label, same product · DailyMed (U.S. National Library of Medicine)

• Theophylline, prednisone, prednisolone, oral contraceptives, fexofenadine, digoxin, warfarin, gemfibrozil, itraconazole, thyroid hormones, sedative hypnotics, NSAIDs, benzodiazepines, decongestants, CYP450 inducersNo dose adjustment needed when co-administered.DailyMed (U.S. National Library of Medicine)

• Published cohort data over decades have not established a drug-associated risk of major birth defects; poorly or moderately controlled asthma in pregnancy increases maternal and fetal risks.International label, same product · DailyMed (U.S. National Library of Medicine)
• Montelukast is present in human milk; available data do not suggest a significant risk of adverse reactions in the breastfed infant.International label, same product · DailyMed (U.S. National Library of Medicine)

• Montelukast: Selective oral antagonist of the cysteinyl leukotriene type-1 (CysLT1) receptor, inhibiting LTD4-mediated airway effects (SINGULAIR US label).